scholarly journals Adsorption behavior of antimicrobial peptide histatin 5 on PMMA

Author(s):  
Masao Yoshinari ◽  
Tetsuo Kato ◽  
Kenichi Matsuzaka ◽  
Tohru Hayakawa ◽  
Takashi Inoue ◽  
...  
Antibiotics ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 494
Author(s):  
Tomoko Komatsu ◽  
Kiyoko Watanabe ◽  
Nobushiro Hamada ◽  
Eva Helmerhorst ◽  
Frank Oppenheim ◽  
...  

There are no studies on Candida colonization and micropeptides of saliva in any patient. Therefore, we studied the effects of the salivary antimicrobial peptide histatin 5 on oral fungal colonization; subjects were subdivided into Down syndrome (D) and normal (N) groups by age: N-1 and D-1, age <20 years; N-2 and D-2, age >40 years. Histatin 5 concentration in saliva was measured by enzyme-linked immunosorbent assay. Oral Candida species were identified using CHROMagar Candida. Candida colonization was significantly enhanced in the D-1 and D-2 groups compared to the N-1 and N-2 groups. There was no predominant difference in salivary histatin 5 concentration between the D-1 and N-1 groups, but it was significantly lower in the D-2 group than in the N-2 group. Only in the N-2 group was there a correlation between the concentration of histatin 5 and total protein, while no correlation was found in the other groups. In elderly patients with Down syndrome, the decrease in histatin 5 shown in this study may lead to oral Candida colony formation. Therefore, the results of this study suggest that a deficiency of the antimicrobial peptide histatin 5 could possibly induce oral Candida infection in DS.


2021 ◽  
Vol 22 (3) ◽  
pp. 1376
Author(s):  
Mafalda Cavalheiro ◽  
Daniela Romão ◽  
Rui Santos ◽  
Dalila Mil-Homens ◽  
Pedro Pais ◽  
...  

Candida glabrata is an emerging fungal pathogen whose success depends on its ability to resist antifungal drugs but also to thrive against host defenses. In this study, the predicted multidrug transporter CgTpo4 (encoded by ORF CAGL0L10912g) is described as a new determinant of virulence in C. glabrata, using the infection model Galleria mellonella. The CgTPO4 gene was found to be required for the C. glabrata ability to kill G. mellonella. The transporter encoded by this gene is also necessary for antimicrobial peptide (AMP) resistance, specifically against histatin-5. Interestingly, G. mellonella’s AMP expression was found to be strongly activated in response to C. glabrata infection, suggesting AMPs are a key antifungal defense. CgTpo4 was also found to be a plasma membrane exporter of polyamines, especially spermidine, suggesting that CgTpo4 is able to export polyamines and AMPs, thus conferring resistance to both stress agents. Altogether, this study presents the polyamine exporter CgTpo4 as a determinant of C. glabrata virulence, which acts by protecting the yeast cells from the overexpression of AMPs, deployed as a host defense mechanism.


2020 ◽  
Vol 21 (7) ◽  
pp. 2654 ◽  
Author(s):  
Kuang-Ting Cheng ◽  
Chih-Lung Wu ◽  
Bak-Sau Yip ◽  
Ya-Han Chih ◽  
Kuang-Li Peng ◽  
...  

In the absence of proper immunity, such as in the case of acquired immune deficiency syndrome (AIDS) patients, Candida albicans, the most common human fungal pathogen, may cause mucosal and even life-threatening systemic infections. P-113 (AKRHHGYKRKFH), an antimicrobial peptide (AMP) derived from the human salivary protein histatin 5, shows good safety and efficacy profiles in gingivitis and human immunodeficiency virus (HIV) patients with oral candidiasis. However, little is known about how P-113 interacts with Candida albicans or its degradation by Candida-secreted proteases that contribute to the fungi’s resistance. Here, we use solution nuclear magnetic resonance (NMR) methods to elucidate the molecular mechanism of interactions between P-113 and living Candida albicans cells. Furthermore, we found that proteolytic cleavage of the C-terminus prevents the entry of P-113 into cells and that increasing the hydrophobicity of the peptide can significantly increase its antifungal activity. These results could help in the design of novel antimicrobial peptides that have enhanced stability in vivo and that can have potential therapeutic applications.


2008 ◽  
Vol 22 (6) ◽  
pp. 1817-1828 ◽  
Author(s):  
Juan Román Luque‐Ortega ◽  
Wim Hof ◽  
Enno C. I. Veerman ◽  
José M. Saugar ◽  
Luis Rivas

Biochemistry ◽  
2006 ◽  
Vol 45 (51) ◽  
pp. 15373-15383 ◽  
Author(s):  
Sonia Melino ◽  
Mariana Gallo ◽  
Edoardo Trotta ◽  
Francesca Mondello ◽  
Maurizio Paci ◽  
...  

Pneumologie ◽  
2006 ◽  
Vol 59 (12) ◽  
Author(s):  
R Shaykhiev ◽  
C Beißwenger ◽  
K Kändler ◽  
J Senske ◽  
A Püchner ◽  
...  

2020 ◽  
Vol 65 (2) ◽  
pp. 119-133
Author(s):  
Nesrimne SEDIIKI ◽  
◽  
Djamel ALIOUCHE ◽  
Imene BOUDHENE ◽  
◽  
...  

2016 ◽  
Author(s):  
Marc Devocelle ◽  
Éanna Forde ◽  
André Schütte ◽  
Andrea Molero-Bondia ◽  
Emer Reeves ◽  
...  

2015 ◽  
Vol 1 (4) ◽  
pp. 76
Author(s):  
Seyadeh Zahra Sajjadiyan ◽  
Sarah Mohammadinejad ◽  
Leila Hassani

Sign in / Sign up

Export Citation Format

Share Document